EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Toward Anti‐Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma‐Associated Herpesvirus Latency‐Associated Nuclear Antigen

Aylin Berwanger iD, Saskia Catherina Stein iD, Sarah Brandner iD, Andreas Martin Kany iD, Sebastian Heinz iD, Brigitta Loretz iD, Claus-Michael Lehr iD, Anna Katharina Herta Hirsch iD, Frederik Lermyte iD, Thomas Friedrich Schulz iD, Martin Empting iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.202500758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Aylin Berwanger und 10 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Centre for Infection Research (HZI)/Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, 66123, Saarbrücken, Germa…. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Antigens, Viral, Antiviral Agents, Nuclear Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Centre for Infection Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaposi's sarcoma‐associated herpesvirus (KSHV) is a gamma‐herpesvirus linked to several malignancies, including Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Among its numerous encoded proteins, the latency‐associated nuclear antigen (LANA) plays a pivotal role in the maintenance of viral latency and oncogenesis. This manuscript focuses on therapeutic strategies aimed at targeting LANA to prevent KSHV‐associated diseases. Following the concept of proteolysis‐targeting chimeras (PROTACs), heterobifunctional compounds are designed and synthesized, which are able to bind LANA as well as specific E3 ligases. To achieve induction of targeted protein degradation, formation of functional ternary complexes as well as uptake into cells is required, which necessitates optimization of multiple compound parameters in parallel. Hence, the conjugates are tested using an assay pipeline tailored for PROTAC drug discovery by checking properties such as binding affinities, formation of ternary complexes, and in vitro absorption, distribution, metabolism, excretion (ADME) data. Restricted permeation as the reason for lack of intracellular target degradation is especially identified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanAntigens, ViralAntiviral AgentsNuclear ProteinsHumansProteolysisMolecular StructureStructure-Activity RelationshipSarcoma, KaposiProteolysis Targeting Chimera

Stichwörter der Autor:innen

Kaposi's sarcoma‐associated herpesviruslatency‐associated nuclear antigennative mass spectrometryproteolysis targeting chimerasternary complex formation

Substanzen

latency-associated nuclear antigenAntigens, ViralAntiviral AgentsNuclear ProteinsProteolysis Targeting Chimera

Autor:innen und Institutionen

  • Helmholtz Centre for Infection Research (HZI)/Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, 66123, Saarbrücken, Germany.
  • Department of Pharmacy, Saarland University, Campus E8.1, 66123, Saarbrücken, Germany.
  • PharmaScienceHub (PSH), Saarland University, Campus E2.1, 66123, Saarbrücken, Germany.
  • German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig,, 66123, Saarbrücken, Germany.
  • Hannover Medical School, Institute of Virology, Carl-Neuberg-Str.1, 30625, Hannover, Germany.
  • Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Carl-Neuberg-Str.1, 30625, Hannover, Germany.

ORCID-Profile: Aylin Berwanger, Saskia Catherina Stein, Sarah Brandner, Andreas Martin Kany, Sebastian Heinz, Brigitta Loretz, Claus-Michael Lehr, Anna Katharina Herta Hirsch, Frederik Lermyte, Thomas Friedrich Schulz, Martin Empting

Förderung

  • German Centre for Infection Research

Zitieren

APA

Berwanger, A., Stein, S. C., Brandner, S., Kany, A. M., Heinz, S., Loretz, B., Lehr, C. M., Hirsch, A. K. H., Lermyte, F., Schulz, T. F., & Empting, M. (2026). Toward Anti‐Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma‐Associated Herpesvirus Latency‐Associated Nuclear Antigen. ChemMedChem. https://doi.org/10.1002/cmdc.202500758

Vancouver

Berwanger A, Stein SC, Brandner S, Kany AM, Heinz S, Loretz B, et al. Toward Anti‐Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma‐Associated Herpesvirus Latency‐Associated Nuclear Antigen. ChemMedChem. 2026. doi:10.1002/cmdc.202500758

BibTeX
@article{Berwanger2026,
  author = {Berwanger, Aylin and Stein, Saskia Catherina and Brandner, Sarah and Kany, Andreas Martin and Heinz, Sebastian and Loretz, Brigitta and Lehr, Claus-Michael and Hirsch, Anna Katharina Herta and Lermyte, Frederik and Schulz, Thomas Friedrich and Empting, Martin},
  title = {Toward Anti‐Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma‐Associated Herpesvirus Latency‐Associated Nuclear Antigen},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.202500758}
}
Kostenlos starten →